Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13,080,549
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
11,218,058
-
Shares change
-
-54,972
-
Total reported value, excl. options
-
$555,064,605
-
Value change
-
-$3,379,103
-
Number of buys
-
67
-
Number of sells
-
-80
-
Price
-
$49.49
Significant Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q1 2022
176 filings reported holding EGRX - EAGLE PHARMACEUTICALS, INC. - Common Stock as of Q1 2022.
EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,218,058 shares
of 13,080,549 outstanding shares and own 86% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,982,333 shares), JANUS HENDERSON GROUP PLC (1,485,404 shares), VANGUARD GROUP INC (780,851 shares), STATE STREET CORP (715,884 shares), BRANDES INVESTMENT PARTNERS, LP (431,850 shares), DIMENSIONAL FUND ADVISORS LP (304,784 shares), AMERIPRISE FINANCIAL INC (264,693 shares), Allspring Global Investments Holdings, LLC (251,979 shares), JPMORGAN CHASE & CO (238,739 shares), and Smith, Graham & Co., Investment Advisors, LP (234,720 shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.